Company
United StatesMolecular Imaging Program at Stanford, Palo Alto, CA – FDA Inspections
Inspection records and compliance data for Molecular Imaging Program at Stanford in Palo Alto, CA. 1 FDA inspection on record, 1 Form 483, last inspected April 17, 2026.
Company Profile
This profile covers Molecular Imaging Program at Stanford based in Palo Alto, CA, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 0
- Unclassified
- 1
- Form 483s
- 1
- Warning letters
- 0
Inspected April 17, 2026.
Most cited issue areas
- Each major production step1 inspection
- Laboratory determination completed1 inspection
- Lab sampling and test procedures1 inspection
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| April 17, 2026 | Not classified | Human Drugs · Generic Drug Evaluation | 1313292 |
FDA documents
Form 483s (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Molecular Imaging Program at Stanford
FEI Number
3038545356
Address
1701 Page Mill Rd, Palo Alto, CA 94304-1210, United States
Country
United States
ID: 0a3fa1d8-1613-450a-a9cc-33c3ff23332d